the nih outbreak story was new to me. i also found the comments on why drug companies are reluctant to develop new antibiotics revealing. unlike cholesterol or cancer drugs which will work the same 30 years from now as they do today, antibiotics are prescribed for brief use, become less effective with each use, and doctors prescribe them sparingly to prolong their life until eventual obsolescence. this makes antibiotics less profitable than other drugs, a much lower return on a pharmaceutical company's investment, creating less incentive for new research and development. a scary thought with several new "super bugs" that resist all current treatments also documented in the report. is this an example of a free market failure? should government attempt to prompt research and development of new antibiotics?